{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:55:09Z","timestamp":1790996109703,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003348","name":"Fukuda Foundation for Medical Technology","doi-asserted-by":"publisher","award":["Fukuda Foundation for Medical Technology"],"award-info":[{"award-number":["Fukuda Foundation for Medical Technology"]}],"id":[{"id":"10.13039\/501100003348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"DOI":"10.1007\/s00380-026-02766-0","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:10:15Z","timestamp":1790993415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Component-level associations of anemia and renal dysfunction with competing first events in acute heart failure with atrial fibrillation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-876X","authenticated-orcid":false,"given":"Jumpei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"2766_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/2048872619894255","volume":"9","author":"B Gorenek","year":"2020","unstructured":"Gorenek B, Halvorsen S, Kudaiberdieva G, Bueno H, Van Gelder IC, Lettino M, Marin F, Masip J, Mueller C, Okutucu S, Poess J, Potpara TS, Price S, Lip GYH (2020) Atrial fibrillation in acute heart failure: a position statement from the Acute Cardiovascular Care Association and European heart rhythm association of the European society of cardiology. Eur Heart J Acute Cardiovasc Care 9:348\u2013357. https:\/\/doi.org\/10.1177\/2048872619894255","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2766_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/ehjqcco\/qcae061","volume":"11","author":"M Austreim","year":"2025","unstructured":"Austreim M, Nouhravesh N, Malik ME, Abassi N, Zahir D, Garred CH, Andersen CF, Hansen ML, Olesen JB, Fosb\u00f8l E, \u00d8stergaard L, K\u00f8ber L, Schou M (2025) Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152,059 patients. Eur Heart J Qual Care Clin Outcomes 11:130\u2013139. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae061","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2766_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.amjcard.2017.02.050","volume":"119","author":"TS Cherian","year":"2017","unstructured":"Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, Thomas L, Kowey PR, Gersh BJ, Mahaffey KW (2017) Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (from the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF]). Am J Cardiol 119:1763\u20131769. https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.050","journal-title":"Am J Cardiol"},{"key":"2766_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/joa3.13031","volume":"40","author":"J Yamamoto","year":"2024","unstructured":"Yamamoto J, Hayama H, Enomoto Y, Yamamoto M, Hara H, Hiroi Y (2024) Impact of left ventricular diastolic function and direct oral anticoagulant use for predicting embolic events in patients with heart failure and atrial fibrillation. J Arrhythm 40:489\u2013500. https:\/\/doi.org\/10.1002\/joa3.13031","journal-title":"J Arrhythm"},{"key":"2766_CR5","doi-asserted-by":"publisher","first-page":"e007230","DOI":"10.1161\/CIRCOUTCOMES.120.007230","volume":"14","author":"CA Jackevicius","year":"2021","unstructured":"Jackevicius CA, Lu L, Ghaznavi Z, Warner AL (2021) Bleeding risk of direct oral anticoagulants in patients with heart failure and atrial fibrillation. Circ Cardiovasc Qual Outcomes 14:e007230. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.120.007230","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2766_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s00380-023-02249-6","volume":"38","author":"J Yamamoto","year":"2023","unstructured":"Yamamoto J, Yamamoto M, Hara H, Hiroi Y (2023) Relation between laxative use and risk of major bleeding in patients with atrial fibrillation and heart failure. Heart Vessels 38:938\u2013948. https:\/\/doi.org\/10.1007\/s00380-023-02249-6","journal-title":"Heart Vessels"},{"key":"2766_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 138:1093\u20131100. https:\/\/doi.org\/10.1378\/chest.10-0134","journal-title":"Chest"},{"key":"2766_CR8","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, L\u00f8chen ML, Lumbers RT, Maesen B, M\u00f8lgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for cardio-thoracic surgery (EACTS). Eur Heart J 45:3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"2766_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2025.07.040","author":"E Soler-Espejo","year":"2025","unstructured":"Soler-Espejo E, Ramos-Bratos MP, Rivera-Caravaca JM, Gonz\u00e1lez-Lozano E, Mar\u00edn F, Rold\u00e1n V, Lip GYH (2025) A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort. J Thromb Haemost. https:\/\/doi.org\/10.1016\/j.jtha.2025.07.040","journal-title":"J Thromb Haemost"},{"key":"2766_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/ehjqcco\/qcab069","volume":"8","author":"M Proietti","year":"2022","unstructured":"Proietti M, Romiti GF, Vitolo M, Potpara TS, Boriani G, Lip GYH (2022) Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry. Eur Heart J Qual Care Clin Outcomes 8:778\u2013786. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab069","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2766_CR11","doi-asserted-by":"publisher","first-page":"574e13","DOI":"10.1016\/j.amjmed.2017.11.046","volume":"131","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Skj\u00f8th F, Nielsen PB, Kj\u00e6ldgaard JN, Larsen TB (2018) The HAS-BLED, ATRIA, and ORBIT bleeding scores in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants. Am J Med 131:574e13\u2013574e27. https:\/\/doi.org\/10.1016\/j.amjmed.2017.11.046","journal-title":"Am J Med"},{"key":"2766_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2016.12.008","volume":"185","author":"BD Westenbrink","year":"2017","unstructured":"Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH (2017) Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J 185:140\u2013149. https:\/\/doi.org\/10.1016\/j.ahj.2016.12.008","journal-title":"Am Heart J"},{"key":"2766_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1253\/circj.CJ-24-0132","volume":"89","author":"T Tsuda","year":"2025","unstructured":"Tsuda T, Hayashi K, Kato T, Kusayama T, Nakagawa Y, Nomura A, Tada H, Usui S, Sakata K, Kawashiri MA, Fujino N, Yamagishi M, Takamura M (2025) Effects of longitudinal changes in anemia status on clinical outcomes in patients with non-valvular atrial fibrillation: analysis from the Hokuriku-Plus AF Registry. Circ J 89:164\u2013173. https:\/\/doi.org\/10.1253\/circj.CJ-24-0132","journal-title":"Circ J"},{"key":"2766_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, van der Cannegieter SC, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236\u2013239","journal-title":"Thromb Haemost"},{"key":"2766_CR15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group (2014) Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): digest version. Circ J 78:1997\u20132021","journal-title":"Circ J"},{"key":"2766_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"2766_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacep.2022.11.032","volume":"9","author":"RM Inciardi","year":"2023","unstructured":"Inciardi RM, Giugliano RP, Park JG, Nordio F, Ruff CT, Chen C, Lanz HJ, Antman EM, Braunwald E, Solomon SD (2023) Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes. JACC Clin Electrophysiol 9:569\u2013580. https:\/\/doi.org\/10.1016\/j.jacep.2022.11.032","journal-title":"JACC Clin Electrophysiol"},{"key":"2766_CR18","doi-asserted-by":"publisher","first-page":"e002975","DOI":"10.1136\/openhrt-2024-002975","volume":"11","author":"NR Jones","year":"2024","unstructured":"Jones NR, Smith M, Lay-Flurrie S, Yang Y, Hobbs FR, Taylor CJ (2024) Heart failure and major haemorrhage in people with atrial fibrillation. Open Heart 11:e002975. https:\/\/doi.org\/10.1136\/openhrt-2024-002975","journal-title":"Open Heart"},{"key":"2766_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/jce.16537","volume":"36","author":"AM Amin","year":"2025","unstructured":"Amin AM, Elbenawi H, Odat RM, Elgebaly M, Al-Shammari AS, Manasrah A, Nakhla M, Ayman D, Ali MA, Helmi A, Abuelazm M, Ternes CMP, Abdelazeem B, Zeb I, Deshmukh AJ, DeSimone CV, d\u2019Avila A (2025) Impact of anemia on clinical outcomes in atrial fibrillation patients on oral anticoagulants: a prognostic meta-analysis. J Cardiovasc Electrophysiol 36:430\u2013448. https:\/\/doi.org\/10.1111\/jce.16537","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2766_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/jcm10010083","volume":"10","author":"M Magnocavallo","year":"2021","unstructured":"Magnocavallo M, Bellasi A, Mariani MV, Fusaro M, Ravera M, Paoletti E, Di Iorio B, Barbera V, Della Rocca DG, Palumbo R, Severino P, Lavalle C, Di Lullo L (2021) Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy. J Clin Med 10:83. https:\/\/doi.org\/10.3390\/jcm10010083","journal-title":"J Clin Med"},{"key":"2766_CR21","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.xkme.2023.100690","volume":"5","author":"MM Law","year":"2023","unstructured":"Law MM, Tan SJ, Wong MCG, Toussaint ND (2023) Atrial fibrillation in kidney failure: challenges in risk assessment and anticoagulation management. Kidney Med 5:100690. https:\/\/doi.org\/10.1016\/j.xkme.2023.100690","journal-title":"Kidney Med"},{"key":"2766_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GYH Lip","year":"2011","unstructured":"Lip GYH, Frison L, Halperin JL, Lane DA (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs\/alcohol concomitantly) score. J Am Coll Cardiol 57:173\u2013180. https:\/\/doi.org\/10.1016\/j.jacc.2010.09.024","journal-title":"J Am Coll Cardiol"},{"key":"2766_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jth.14692","volume":"18","author":"G Chang","year":"2020","unstructured":"Chang G, Xie Q, Ma L, Hu K, Zhang Z, Mu G, Cui Y (2020) Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: a network meta-analysis. J Thromb Haemost 18:791\u2013801. https:\/\/doi.org\/10.1111\/jth.14692","journal-title":"J Thromb Haemost"},{"key":"2766_CR24","doi-asserted-by":"publisher","first-page":"oeae053","DOI":"10.1093\/ehjopen\/oeae053","volume":"4","author":"AM Ajabnoor","year":"2024","unstructured":"Ajabnoor AM, Zghebi SS, Parisi R, Ashcroft DM, Faivre-Finn C, Mamas MA, Kontopantelis E (2024) Performance of CHA\u2082DS\u2082-VASc and HAS-BLED in predicting stroke and bleeding in atrial fibrillation and cancer. Eur Heart J Open 4:oeae053. https:\/\/doi.org\/10.1093\/ehjopen\/oeae053","journal-title":"Eur Heart J Open"},{"key":"2766_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/eurheartj\/ehs435","volume":"34","author":"GYH Lip","year":"2013","unstructured":"Lip GYH (2013) Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 34:1041\u20131049. https:\/\/doi.org\/10.1093\/eurheartj\/ehs435","journal-title":"Eur Heart J"},{"key":"2766_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rec.2024.02.011","volume":"77","author":"MJ Serna","year":"2024","unstructured":"Serna MJ, Rivera-Caravaca JM, L\u00f3pez-G\u00e1lvez R, Soler-Espejo E, Lip GYH, Mar\u00edn F, Rold\u00e1n V (2024) Dynamic assessment of CHA\u2082DS\u2082-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed) 77:835\u2013842. https:\/\/doi.org\/10.1016\/j.rec.2024.02.011","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2766_CR27","doi-asserted-by":"publisher","first-page":"O14","DOI":"10.1093\/eurheartj\/suaa178","volume":"22","author":"DA Lane","year":"2020","unstructured":"Lane DA, Lip GYH (2020) Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal. Eur Heart J Suppl 22:O14\u2013O27. https:\/\/doi.org\/10.1093\/eurheartj\/suaa178","journal-title":"Eur Heart J Suppl"},{"key":"2766_CR28","doi-asserted-by":"publisher","first-page":"101443","DOI":"10.1016\/j.ijcha.2024.101443","volume":"53","author":"K Giskes","year":"2024","unstructured":"Giskes K, Lowres N, Orchard J, Hyun K, Hespe C, Freedman B (2024) Time trends in stroke risk management among high-risk patients with non-valvular atrial fibrillation in Australia between 2011\u20132019. IJC Heart Vasc 53:101443. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101443","journal-title":"IJC Heart Vasc"},{"key":"2766_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12872-024-04133-1","volume":"24","author":"M Zhang","year":"2024","unstructured":"Zhang M, Zhou J (2024) Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure. BMC Cardiovasc Disord 24:495. https:\/\/doi.org\/10.1186\/s12872-024-04133-1","journal-title":"BMC Cardiovasc Disord"},{"key":"2766_CR30","doi-asserted-by":"publisher","first-page":"e040758","DOI":"10.1161\/JAHA.124.040758","volume":"14","author":"E Jalli","year":"2025","unstructured":"Jalli E, Lang\u00e9n V, Jaakkola J, Airaksinen KEJ, Halminen O, Putaala J, Mustonen P, Haukka J, Hartikainen J, Linna M, Lehto M, Teppo K (2025) Heart failure and stroke risk in atrial fibrillation: temporal trends from a nationwide cohort study. J Am Heart Assoc 14:e040758. https:\/\/doi.org\/10.1161\/JAHA.124.040758","journal-title":"J Am Heart Assoc"},{"key":"2766_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00380-023-02343-9","volume":"39","author":"E Kodani","year":"2024","unstructured":"Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Origasa H (2024) Characteristics and outcomes in elderly patients with non-valvular atrial fibrillation and high bleeding risk: subanalysis of the J-RHYTHM Registry. Heart Vessels 39:330\u2013339. https:\/\/doi.org\/10.1007\/s00380-023-02343-9","journal-title":"Heart Vessels"},{"key":"2766_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00380-024-02445-y","volume":"40","author":"H Wada","year":"2025","unstructured":"Wada H, Miyauchi K, Suwa S, Miyazaki S, Hayashi H, Nishizaki Y, Yanagisawa N, Yokoyama K, Murata N, Saito Y, Nagashima K, Matsumoto N, Okumura Y, Minamino T, Daida H (2025) Major bleeding increases the risk of subsequent cardiovascular events in patients with atrial fibrillation: insights from the SAKURA AF registry and RAFFINE registry. Heart Vessels 40:123\u2013130. https:\/\/doi.org\/10.1007\/s00380-024-02445-y","journal-title":"Heart Vessels"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-026-02766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-026-02766-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-026-02766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:10:16Z","timestamp":1790993416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-026-02766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":32,"alternative-id":["2766"],"URL":"https:\/\/doi.org\/10.1007\/s00380-026-02766-0","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"8 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the National Center for Global Health and Medicine (JIHS-S-005141-00) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for individual informed consent was waived owing to the retrospective design and use of de-identified data, with an opt-out option.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}